Trial Profile
Clinical Trials Insight: 700025378
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2008
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Inspire Pharmaceuticals
- 27 Jul 2007 New trial record.